sitagliptin phosphate anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

155 API Suppliers, 66 USDMF, 25 CEP/COS, 6 JDMF, 24 EU WC, 6 KDMF, 42 NDC API, 98 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

55 Intermediates Suppliers

55 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

551 FDF Dossiers, 65 FDA Orange Book, 231 Europe, 80 Australia, 11 South Africa, 164 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - 1GM;EQ 50MG BASE, TABLET;ORAL - 500MG;EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 Minakem, 2 SPI Pharma, 2 Seqens, 11 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 35 Fillers, Diluents & Binders, 30 Controlled & Modified Release, 23 Lubricants & Glidants, 19 Disintegrants & Superdisintegrants, 18 Direct Compression, 17 Thickeners and Stabilizers, 13 Granulation, 11 Topical, 10 Co-Processed Excipients, 8 Film Formers & Plasticizers, 8 API Stability Enhancers, 7 Solubilizers, 6 Taste Masking, 5 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 4 Emulsifying Agents, 4 Parenteral, 4 Vegetarian Capsules, 3 Rheology Modifiers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

16 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 130 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 200 Finished Drug Prices, 17 Annual Reports

MARKET PLACE

41 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

45 US Patents, 16 US Exclusivities, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21995 / DOSAGE - TABLET;ORAL - EQ 100MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SITAGLIPTIN PHOSPHATE(UNII: TS63EW8X6F) (SITAGLIPTIN - UNII:QFP0P1DV7Z)	SITAGLIPTIN	100mg

Inactive Ingredients

Ingredient Name	Avera McKennan Hospital	Cardinal Health	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	A-S Medication Solutions	REMEDYREPACK INC.
ANHYDROUS DIBASIC CALCIUM PHOSPHATE(L11K75P92J)
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS(L11K75P92J)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSCARMELLOSE SODIUM(M28OL1HH48)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
magnesium stearate(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYETHYLENE GLYCOLS(3WJQ0SDW1A)
POLYVINYL ALCOHOL(532B59J990)
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
SODIUM STEARYL FUMARATE(7CV7WJK4UI)
talc(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: sitagliptin phosphate anhydrous